Home / Brands / Akcea Therapeutics

Akcea Therapeutics Recalls

1 recall on record · July 6, 2022 to July 6, 2022 · Drugs

July 6, 2022DrugsFDA

Akcea Therapeutics, Inc. recalls Tegsedi (inotersen) Injection 284 mg/1.5 mL, Rx Only, Sterile solution for Subcutaneous Use, 4 prefilled syringes, each

Hazard: Superpotent: High Out of specification (OOS) test result for percent label claim (%LC).

Akcea Therapeutics Recalls | RecallWatchUSA